MolecularMD Lands $3,000,000 New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    2611 SW 3rd Ave. Portland, OR 97201
  • Company Description
    Founded in 2006, MolecularMD is a molecular diagnostics company specializing in clinical development and commercialization of state-of-the-art genomic assays to measure patient response and resistance to targeted cancer therapies. The company has over 30 years of combined experience in cancer research and has developed sensitive and highly reliable molecular assays for leukemias, lymphomas, and solid tumors.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    This financing will be used to build MolecularMD’s corporate infrastructure and to expand the company’s assay portfolio.
  • M&A Terms
  • Venture Investor
    Ballast Point Venture Partners